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Discussion
Dr Carl L. Backer (Chicago, Ill). It is a great privilege for me
to discuss this outstanding review of recoarctation management.
The outcome reported here with reoperation for recoarctation is
truly superb, with only 1 death (in a complex neonate) in 63
patients. There were no episodes of postoperative paraplegia, and
only 2 patients required a second reoperation.
In contrast, of the 42 patients having transcatheter balloon
dilatation, 14 have undergone or are awaiting a reoperation, and 4
had major complications. In light of these excellent results, the
question I believe the authors should have asked in the title is this:
“Is balloon dilatation still indicated in recurrent aortic arch ob-
struction?”
Our results at Children’s Memorial Hospital are quite similar to
yours. We reported a 40-year experience with more than 30 pa-
tients having recoarctation surgery with no mortality and no para-
plegia. In our series 30% of the patients who had a balloon
dilatation required an eventual operative intervention. However,
we had no major complications from balloon dilatation at our
institution. I believe that the learning curve for balloon dilatation
has occurred in recoarctation and that the results of balloon dila-
tation are improving.
Recent use of stents and covered stents will continue to show
improvement with recoarctation balloon dilatation. What I believe
is important is a continued collaboration between the surgeon and
the pediatric interventional cardiologist to define the optimal man-
agement strategy for these patients at the individual institutions.
I have several questions.
We used a recoarctation analysis to identify what we believed
was the best primary operation for coarctation. Can you make a
comment about your current primary procedure of choice for
coarctation?
My next question relates to the prevention of paraplegia. What
intraoperative techniques did you use to attain the excellent result
of no postoperative paraplegia in this large series? Also, as a
corollary to this question, when did you use CPB support, aside
from those patients operated on through a median sternotomy?
My final question relates to a question of definitions. It was
interesting to me that you defined recoarctation in your article as
systolic echocardiographic gradient plus diastolic flow prolonga-
tion. You never mentioned arm-leg blood pressure gradients or
cardiac catheterization gradients. Do you still consider a 20-mm
arm-leg gradient to be the gold standard for defining recoarctation,
or do you believe the echocardiographic criteria have supplanted
this?
I very much enjoyed reviewing this manuscript and believe that
this is an important contribution to our knowledge of the results of
recoarctation surgery.
Dr Zoghbi. Thank you, Dr Backer, for your comments.
I am going to start with the third question, which is about the
definition of recoarctation or coarctation. It is true that this defi-
nition remains under debate. In our experience and on the basis of
the literature, we have chosen to define the coarctation when
diastolic prolongation of the flow is present at any site of the aortic
arch. When reviewing the patients, indeed, some of them had
normal dimension of their aortic segments at the site of primary
repair with only diastolic gradient. These patients presented with
systemic hypertension, and at reoperation, we found a restricted
aortic diameter at the site of primary repair. We have never seen
false-positive cases with this definition.
Regarding the prevention of cardioplegia, when recoarctation
repair is done by means of sternotomy, patients undergo CPB with
deep hypothermia. But for patients having a thoracotomy, systemic
pressure is monitored at the radial and femoral sites, and if femoral
pressure decreases to less than 50 mm Hg at crossclamp time, CPB
is done between the femoral artery and the femoral vein or the
pulmonary artery of the left atrium. In addition, when we consider
that the reoperation is going to be long, with a long clamping time,
cardiopulmonary circulatory support is also provided.
Actually, in our institution all the patients who present with
recoarctation undergo balloon dilation, which is probably the same
as in other centers. In this study we present our results, and we find
that in patients older than 4 years, the recurrence rate is very high.
We still do not have experience with stenting, but perhaps this is
going to improve the results. In the presence of aortic hypoplasia,
surgical intervention is the only indication, and dilation has no
place.
Dr Backer. And what is your primary procedure of choice for
coarctation?
Dr Zoghbi. The primary procedure is still extended end-to-end
anastomosis, which has been done in our institution for more than
10 years and provides satisfactory results, especially when there is
no proximal hypoplasia of the aortic arch.
Dr Zahid Amin (Omaha, Neb). Clearly the balloon dilation
for recurrent coarctation is the procedure of choice in the
United States. The data you presented have combined arch
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obstruction and coarctation of aorta, which is like comparing
apples and oranges. I believe that the majority of patients with
arch obstruction undergo surgical intervention because cardiol-
ogists do not want to intervene. Obviously, the results of
balloon dilation of the aortic arch will not be as good as for
coarctation of the aorta. I was wondering if you can clarify how
many patients had recoarctation after balloon angioplasty and
how many of them had angioplasty for arch obstruction. I
believe that if we mix these 2 entities and conclude that balloon
angioplasty failed, we might not be fair to our fellow cardiol-
ogists.
Dr Zoghbi. Some of the patients present with both recoarcta-
tion and aortic hypoplasia, and sometimes we do not know which
of the 2 is responsible for the symptoms. And some cardiologists
prefer to dilate the recoarctation and to see the results. This
happened in 4 patients.
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